# Potential cost savings owing to the route of administration of oncology drugs

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/potential-cost-savings-owing-to-the-route-of-administration-of-oncology-drugs/

## Facts

| Field | Value |
| --- | --- |
| Author Names | M Franken,Tim A. Kanters,Jules L.L.M. Coenen,Paul de Jong,Harry R. Koene,Pieternella J. Lugtenburg,Agnes Jager,Carin A. Uyl‐de Groot |
| Citations | 36 |
| DOI | 10.1097/cad.0000000000000648 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://pure.eur.nl/en/publications/608a1c7a-8ec3-4f24-a024-213e516597de |
| OpenAlex ID | https://openalex.org/W2805001001 |
| PMID | 29846248 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Tim A. Kanters](https://scholariq.org/researchers/tim-a-kanters/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.